{"entity":{"id":"nct06117540","kind":"trial","name":"A Study of WX390 in Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 2 trial of WX390 in advanced solid tumours, run by Shanghai Jiatan Pharmatech Co., Ltd, now recruiting.","summary":"A Study of WX390 in Patients With Advanced Solid Tumors is a phase 2 interventional study registered as NCT06117540 by Shanghai Jiatan Pharmatech Co., Ltd, with 70 participants planned, started 2021-05-11 and due to reach its primary completion in 2025-06-12. Interventions recorded: WX390.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06117540","url":"https://clinicaltrials.gov/study/NCT06117540"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06117540","phase":"2","setting":"An Open-label, Single-arm, Multicenter Phase II Clinical Study to Evaluate the Efficacy and Safety of WX390 in Patients With Advanced Solid Tumors","sponsor":"Shanghai Jiatan Pharmatech Co., Ltd","enrolled":70,"outcomes":[]},"route":"/trials/nct06117540/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}